Skip to content
Open access

Toward comprehensive maps of somatic mosaic mutations.

Nov 2026 · Cell Genomics · pp. 101401 · 0 citations · 10 references
Medicine

TL;DR

These studies show that detection performance depends on reference representation, benchmark quality, and experimental design, requiring careful calibration when integrating technologies.

Abstract

The Somatic Mosaicism across Human Tissues Network has established complementary benchmarks for somatic mutation detection, extended mutation analysis into underexplored genomic regions, and highlighted chromatin states as potential records of cellular history. These studies show that detection performance depends on reference representation, benchmark quality, and experimental design, requiring careful calibration when integrating technologies.

Read PDF

Similar papers

Sep 2026

Beyond genes and hotspots: Protein-informed interpretation of cancer mutations.

This issue of Cancer Cell, Hyeon et al. identify and map significantly mutated regions to protein domains and structural features, establishing a proteo-genomics framework for interpreting cancer mutations beyond genes and hotspots.

Mei Luo, Leng Han · 0 citations
Oct 2026

Charting the silent variation within us.

The SMaHT Network now delivers benchmarked tools and the first body-wide map of somatic mosaicism, establishing a baseline of "normal" against which its roles in development, aging, and disease can finally be tested.

Jacey R. Pridgen, Margaret A. Goodell · 0 citations
Open access Oct 2026

Comprehensive benchmarking of somatic mutation detection by the SMaHT Network.

Somatic mosaicism is increasingly recognized as a fundamental feature of human biology, yet the detection of somatic mutations remains challenging. The Somatic Mosaicism across Human Tissues (SMaHT) Network conducted large-scale benchmarking experiments involving cell lines and donor tissues to evaluate sequencing tech...

A. Abyzov, Abhiram Natu, Adam Voshall et al. · 3 citations
Review Open access Oct 2026

Cell-free DNA fragmentomics and epigenomic profiling in hematologic malignancies: current evidence, translational limitations, and future directions

Highlights • Evidence mapping separates direct plasma studies from indirect support.• Fragmentomic and epigenomic signals may complement mutation testing.• Lineage-associated methylation does not establish malignant fraction.• Multimodal profiling often requires separate assays and integration.• Most applications still...

Amr A. El-Sehrawy, Sarmad S. Abdullah, Guzalya Mamedova et al. · 0 citations
Oct 2026

Genome-wide human T cell screens: barriers and design.

Liu et al. enabled genome-wide clustered regularly interspaced short palindromic repeats (CRISPR) screening of primary human T cells in vivo and identified P2RY8 and GNAS through complementary functional readouts. We discuss how context shapes perturbation effects, and how readouts guide prioritization, with implicatio...

Jie-Liu-Xiao-Hui-Yang-Fan-Zhu-Xue-Dong Zhong, Jia-Jia Wang, Chen Wang et al. · 0 citations
Open access Oct 2026

A pangenomic method for establishing a synthetic somatic variant resource in HapMap mixtures.

Evaluating multiple callers showed that telomere-to-telomere CHM13 alignment improves structural variant detection and offers advantages in difficult-to-map regions compared to GRCh38, and a binomial-based model was developed to estimate coverage requirements for variant detection.

Nahyun Kong, Zi-Tian Tang, Andrew Ruttenberg et al. · 2 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.